Applied Therapeutics News and Activities

Applied Therapeutics is a company listed under the stock ticker APLT (US).

Acquisition, funding and merger involving Applied Therapeutics.

• Cycle Pharmaceuticals has acquired Applied Therapeutics (posted on February 3 2026).
• Cycle Pharmaceuticals has announced the acquisition of Applied Therapeutics  (posted on December 15 2025).

View the org chart displaying its 7 main executives

Most searched biographies at Applied Therapeutics

• Les Funtleyder, Interim Chief Executive Officer and Chief Financia...
• Dottie caplan, Executive Vice President, Patient Advocacy and Gove...
• Ray Coggins, Senior Vice President, Head of Marketing

Popular executive movements at Applied Therapeutics

• Brian Walls, Vice President of Market Access, has left the company  (posted on May 5 2026).
• Constantine Chinoporos, Chief Operating Officer and Chief Business Officer, has left the company  (posted on March 27 2026).
• Dale Hooks, Chief Commercial Officer, has left the company  (posted on March 9 2026).

Click here to view some more movements at Applied Therapeutics

Create your alert
to follow the executive moves at Applied Therapeutics.

Applied Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Applied Therapeutics

• Applied Therapeutics Appoints Reena Thomas Colacot as Vice President and Head of Quality | Applied Therapeutics
• Applied Therapeutics Appoints John H. Johnson as Executive Chairman | Applied Therapeutics
• Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia | Applied Therapeutics
• Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference | Applied Therapeutics
• Applied Therapeutics Reports Third Quarter 2024 Financial Results | Applied Therapeutics
• Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia | Applied Therapeutics
• Applied Therapeutics to Participate in Upcoming Investor Conferences | Applied Therapeutics
• Applied Therapeutics Reports Second Quarter 2024 Financial Results | Applied Therapeutics
• Applied Therapeutics Added to Russell 3000® Index | Applied Therapeutics
• Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference | Applied Therapeutics
• View more press releases Close

Social media about Applied Therapeutics

• Applied Therapeutics on Wikipedia, Google News & Yahoo Finance
• Applied Therapeutics on LinkedIn, X (Twitter) & YouTube